C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer

The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progre...

Full description

Saved in:

Bibliographic Details
Published in	Scientific reports Vol. 11; no. 1; pp. 10078 - 14
Main Authors	Ono, Hiroaki, Kato, Tomotaka, Murase, Yoshiki, Nakamura, Yutaro, Ishikawa, Yoshiya, Watanabe, Shuichi, Akahoshi, Keiichi, Ogura, Toshiro, Ogawa, Kosuke, Ban, Daisuke, Kudo, Atsushi, Akiyama, Yoshimitsu, Tanaka, Shinji, Ito, Hiromichi, Tanabe, Minoru
Format	Journal Article
Language	English
Published	London Nature Publishing Group UK 12.05.2021 Nature Publishing Group Nature Portfolio
Subjects	631/67/1504/1713 692/4028/546 Acetylation Carcinogenesis Cell cycle Cell proliferation CREB-binding protein Cyclic AMP response element-binding protein Cyclin B1 Cyclin-dependent kinases Epigenetics Histone H3 Histones Humanities and Social Sciences Kinases Medical prognosis multidisciplinary Pancreatic cancer Patients Regulatory proteins Science Science (multidisciplinary) siRNA Transcription Tumors Xenografts
Online Access	Get full text
ISSN	2045-2322 2045-2322
DOI	10.1038/s41598-021-89530-8

Cover

Abstract	The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progression. However, in pancreatic cancer, the clinical relevance of HAT activity and histone acetylation has remained unclear. We identified that H3 acetylation was expressed in all pancreatic cancer patients, indicating that H3 acetylation may be essential in pancreatic cancer cells. We also found that the HAT inhibitor C646 augmented anti-tumor effects in vitro by inhibiting cell proliferation and cell cycle progression concomitantly with suppression of acetylated H3K9 and H3K27 expression. C646 or p300 and CBP (CREB-binding protein)-specific siRNA treatment inhibited the transcription of the G2/M cell cycle regulatory proteins cyclin B1 and CDK1 (cyclin-dependent kinase 1). C646 treatment also inhibited tumor growth in vivo in a xenograft mouse model. C646 could be an effective therapeutic agent for pancreatic cancer. The epigenetic status of pancreatic cancers based on their level of histone H3 acetylation may influence patient survival. Epigenetic stratification according to H3K27 acetylation could be useful for predicting disease prognosis as well as the therapeutic efficacy of C646 in pancreatic cancer.
AbstractList	The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progression. However, in pancreatic cancer, the clinical relevance of HAT activity and histone acetylation has remained unclear. We identified that H3 acetylation was expressed in all pancreatic cancer patients, indicating that H3 acetylation may be essential in pancreatic cancer cells. We also found that the HAT inhibitor C646 augmented anti-tumor effects in vitro by inhibiting cell proliferation and cell cycle progression concomitantly with suppression of acetylated H3K9 and H3K27 expression. C646 or p300 and CBP (CREB-binding protein)-specific siRNA treatment inhibited the transcription of the G2/M cell cycle regulatory proteins cyclin B1 and CDK1 (cyclin-dependent kinase 1). C646 treatment also inhibited tumor growth in vivo in a xenograft mouse model. C646 could be an effective therapeutic agent for pancreatic cancer. The epigenetic status of pancreatic cancers based on their level of histone H3 acetylation may influence patient survival. Epigenetic stratification according to H3K27 acetylation could be useful for predicting disease prognosis as well as the therapeutic efficacy of C646 in pancreatic cancer. Abstract The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progression. However, in pancreatic cancer, the clinical relevance of HAT activity and histone acetylation has remained unclear. We identified that H3 acetylation was expressed in all pancreatic cancer patients, indicating that H3 acetylation may be essential in pancreatic cancer cells. We also found that the HAT inhibitor C646 augmented anti-tumor effects in vitro by inhibiting cell proliferation and cell cycle progression concomitantly with suppression of acetylated H3K9 and H3K27 expression. C646 or p300 and CBP (CREB-binding protein)-specific siRNA treatment inhibited the transcription of the G2/M cell cycle regulatory proteins cyclin B1 and CDK1 (cyclin-dependent kinase 1). C646 treatment also inhibited tumor growth in vivo in a xenograft mouse model. C646 could be an effective therapeutic agent for pancreatic cancer. The epigenetic status of pancreatic cancers based on their level of histone H3 acetylation may influence patient survival. Epigenetic stratification according to H3K27 acetylation could be useful for predicting disease prognosis as well as the therapeutic efficacy of C646 in pancreatic cancer. The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progression. However, in pancreatic cancer, the clinical relevance of HAT activity and histone acetylation has remained unclear. We identified that H3 acetylation was expressed in all pancreatic cancer patients, indicating that H3 acetylation may be essential in pancreatic cancer cells. We also found that the HAT inhibitor C646 augmented anti-tumor effects in vitro by inhibiting cell proliferation and cell cycle progression concomitantly with suppression of acetylated H3K9 and H3K27 expression. C646 or p300 and CBP (CREB-binding protein)-specific siRNA treatment inhibited the transcription of the G2/M cell cycle regulatory proteins cyclin B1 and CDK1 (cyclin-dependent kinase 1). C646 treatment also inhibited tumor growth in vivo in a xenograft mouse model. C646 could be an effective therapeutic agent for pancreatic cancer. The epigenetic status of pancreatic cancers based on their level of histone H3 acetylation may influence patient survival. Epigenetic stratification according to H3K27 acetylation could be useful for predicting disease prognosis as well as the therapeutic efficacy of C646 in pancreatic cancer.The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases). It is likely that malfunction of this enzymatic machinery controlling epigenetic modification is relevant to carcinogenesis and tumor progression. However, in pancreatic cancer, the clinical relevance of HAT activity and histone acetylation has remained unclear. We identified that H3 acetylation was expressed in all pancreatic cancer patients, indicating that H3 acetylation may be essential in pancreatic cancer cells. We also found that the HAT inhibitor C646 augmented anti-tumor effects in vitro by inhibiting cell proliferation and cell cycle progression concomitantly with suppression of acetylated H3K9 and H3K27 expression. C646 or p300 and CBP (CREB-binding protein)-specific siRNA treatment inhibited the transcription of the G2/M cell cycle regulatory proteins cyclin B1 and CDK1 (cyclin-dependent kinase 1). C646 treatment also inhibited tumor growth in vivo in a xenograft mouse model. C646 could be an effective therapeutic agent for pancreatic cancer. The epigenetic status of pancreatic cancers based on their level of histone H3 acetylation may influence patient survival. Epigenetic stratification according to H3K27 acetylation could be useful for predicting disease prognosis as well as the therapeutic efficacy of C646 in pancreatic cancer.
ArticleNumber	10078
Author	Nakamura, Yutaro Ono, Hiroaki Murase, Yoshiki Watanabe, Shuichi Akahoshi, Keiichi Kudo, Atsushi Ishikawa, Yoshiya Ogawa, Kosuke Ito, Hiromichi Ban, Daisuke Tanaka, Shinji Tanabe, Minoru Akiyama, Yoshimitsu Kato, Tomotaka Ogura, Toshiro
Author_xml	– sequence: 1 givenname: Hiroaki surname: Ono fullname: Ono, Hiroaki email: ono.msrg@tmd.ac.jp organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Department of Surgery, College of Human Medicine, Michigan State University – sequence: 2 givenname: Tomotaka surname: Kato fullname: Kato, Tomotaka organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 3 givenname: Yoshiki surname: Murase fullname: Murase, Yoshiki organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 4 givenname: Yutaro surname: Nakamura fullname: Nakamura, Yutaro organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 5 givenname: Yoshiya surname: Ishikawa fullname: Ishikawa, Yoshiya organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 6 givenname: Shuichi surname: Watanabe fullname: Watanabe, Shuichi organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 7 givenname: Keiichi surname: Akahoshi fullname: Akahoshi, Keiichi organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 8 givenname: Toshiro surname: Ogura fullname: Ogura, Toshiro organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 9 givenname: Kosuke surname: Ogawa fullname: Ogawa, Kosuke organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 10 givenname: Daisuke surname: Ban fullname: Ban, Daisuke organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 11 givenname: Atsushi surname: Kudo fullname: Kudo, Atsushi organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 12 givenname: Yoshimitsu surname: Akiyama fullname: Akiyama, Yoshimitsu organization: Division of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 13 givenname: Shinji surname: Tanaka fullname: Tanaka, Shinji organization: Division of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University – sequence: 14 givenname: Hiromichi surname: Ito fullname: Ito, Hiromichi organization: Department of Surgery, College of Human Medicine, Michigan State University – sequence: 15 givenname: Minoru surname: Tanabe fullname: Tanabe, Minoru organization: Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33980911$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uk1v1DAQtVARLaV_gAOKxIVLqL9jX5DQCkqlIi5wthxnsvUqay-2g9R_j9O00PbQuXjsee_peWZeo6MQAyD0luCPBDN1njkRWrWYklZpwXCrXqATirloKaP06EF-jM5y3uEagmpO9Ct0zJhWWBNygsaN5LLx4dr3vuTmgp5_bxxMU-Nu3ARtgskWGJpDigV8yI0N9VLzUHwtLPfi2zLvY2pgHMFVDR-agw0ugS3eNa6mkN6gl6OdMpzdnafo19cvPzff2qsfF5ebz1etk1iWVmsFwIFZNwjHhRipk2A7Nsi-A6pHQoXrheIdHyTmSvNhsJJ2kmLb6_rMTtHlqjtEuzOH5Pc23Zhovbl9iGlrbKq2JjDgFONMuxFry3s7aMo7OwLpOmUpdqxqfVq1DnO_h8HVPyc7PRJ9XAn-2mzjH6MIEZjzKvDhTiDF3zPkYvY-L821AeKcDRVUMkw7skDfP4Hu4pxCbdWCEqoG0RX17qGjf1bux1kBagW4FHNOMBrnSx1DXAz6yRBsluUx6_KYujzmdnmMqlT6hHqv_iyJraRcwWEL6b_tZ1h_Acie1g0
CitedBy_id	crossref_primary_10_1007_s10565_024_09984_0 crossref_primary_10_1016_j_omton_2024_200871 crossref_primary_10_1016_j_jtbi_2023_111608 crossref_primary_10_1172_jci_insight_174264 crossref_primary_10_1097_MPA_0000000000002342 crossref_primary_10_3390_cancers14164050 crossref_primary_10_1016_j_chembiol_2024_05_016 crossref_primary_10_3389_fphar_2024_1308309 crossref_primary_10_4062_biomolther_2024_156 crossref_primary_10_3389_fcell_2022_909557 crossref_primary_10_1038_s41392_022_01245_y crossref_primary_10_1007_s10555_023_10132_z crossref_primary_10_3390_ijms25094647 crossref_primary_10_1073_pnas_2116764119 crossref_primary_10_3389_fendo_2022_972312 crossref_primary_10_3390_antiox10091356 crossref_primary_10_1186_s13148_024_01709_8 crossref_primary_10_3390_cancers14040894 crossref_primary_10_1007_s10142_024_01353_8 crossref_primary_10_1080_17501911_2024_2447807 crossref_primary_10_1021_acschembio_3c00293 crossref_primary_10_3892_ijo_2024_5614
Cites_doi	10.18632/oncotarget.10117 10.1158/0008-5472.CAN-14-0155 10.1074/jbc.M301580200 10.1093/nar/gkq244 10.1016/j.biopha.2016.12.034 10.1074/jbc.M409024200 10.1002/ijc.32072 10.1038/emboj.2010.318 10.1073/pnas.1016071107 10.1101/gad.931401 10.1101/gad.255182.114 10.1371/journal.pone.0096060 10.1111/j.1432-1033.2004.04162.x 10.1007/s00412-015-0508-y 10.18632/oncotarget.26704 10.3322/caac.21551 10.1038/nature07829 10.1158/2159-8290.CD-15-0754 10.3892/ijmm.2012.966 10.1038/nature14169 10.1038/ng.3470 10.1158/2159-8290.CD-18-0275 10.3390/epigenomes3020011 10.3892/etm.2018.6345 10.1016/j.cell.2013.09.053 10.3892/ijo.2017.4176 10.1016/j.ccell.2018.02.003 10.1038/nature09906 10.1136/gutjnl-2016-312539 10.1038/nm.3336 10.1038/sj.bjc.6605039 10.1158/0008-5472.CAN-06-3066 10.1158/1541-7786.MCR-15-0034 10.15252/embj.201592404 10.1016/j.cell.2017.07.007 10.1016/j.cell.2016.12.013 10.1016/j.chembiol.2010.03.006 10.1126/science.aal2380 10.1007/s12029-011-9257-1 10.1126/science.1164368 10.1016/j.radonc.2014.03.015 10.1016/j.cell.2013.02.014 10.1016/j.trecan.2017.03.006 10.1371/journal.pone.0055481 10.1158/0008-5472.CAN-06-4257 10.1242/jcs.00735 10.1186/1471-2164-13-424
ContentType	Journal Article
Copyright	The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA
DOI	10.1038/s41598-021-89530-8
DatabaseName	Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	PubMed CrossRef MEDLINE - Academic Publicly Available Content Database
Database_xml	– sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2045-2322
EndPage	14
ExternalDocumentID	oai_doaj_org_article_ec83439cf09a4bad9247afe1778a20c3 PMC8115044 33980911 10_1038_s41598_021_89530_8
Genre	Journal Article
GrantInformation_xml	– fundername: JSPS KAKENHI Grant-in-Aid for Research Activity Start-up grantid: 16H06773 – fundername: ; grantid: 16H06773
GroupedDBID	0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c606t-998ee4e3acd5c455f2c6ea73d6b7e29f125cb58474d604894dda627620ab98473
IEDL.DBID	M48
ISSN	2045-2322
IngestDate	Wed Aug 27 01:25:35 EDT 2025 Thu Aug 21 18:23:19 EDT 2025 Fri Sep 05 12:43:51 EDT 2025 Wed Aug 13 10:55:07 EDT 2025 Thu Apr 03 07:05:41 EDT 2025 Tue Jul 01 03:48:24 EDT 2025 Thu Apr 24 22:55:17 EDT 2025 Fri Feb 21 02:39:38 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c606t-998ee4e3acd5c455f2c6ea73d6b7e29f125cb58474d604894dda627620ab98473
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-89530-8
PMID	33980911
PQID	2525888819
PQPubID	2041939
PageCount	14
ParticipantIDs	doaj_primary_oai_doaj_org_article_ec83439cf09a4bad9247afe1778a20c3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8115044 proquest_miscellaneous_2526302714 proquest_journals_2525888819 pubmed_primary_33980911 crossref_citationtrail_10_1038_s41598_021_89530_8 crossref_primary_10_1038_s41598_021_89530_8 springer_journals_10_1038_s41598_021_89530_8
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2021-05-12
PublicationDateYYYYMMDD	2021-05-12
PublicationDate_xml	– month: 05 year: 2021 text: 2021-05-12 day: 12
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Scientific reports
PublicationTitleAbbrev	Sci Rep
PublicationTitleAlternate	Sci Rep
PublicationYear	2021
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	Lee, Young (CR26) 2013; 152 Andricovich (CR32) 2018; 33 Kunnumakkara (CR40) 2007; 67 Wang (CR16) 2017; 51 Sahu, Batra, Srivastava (CR43) 2009; 100 Rahib (CR2) 2014; 74 Waddell (CR5) 2015; 518 Lee (CR14) 2012; 30 Ono, Basson, Ito (CR44) 2014; 9 Flavahan, Gaskell, Bernstein (CR38) 2017 Bradner, Hnisz, Young (CR25) 2017; 168 Ghosh (CR34) 2019; 10 Oike (CR15) 2014; 111 Hu, Xu, Meng, Huang, Sun (CR42) 2018; 16 Jin (CR24) 2011; 30 Hnisz (CR31) 2013; 155 Pasini (CR22) 2010; 38 Heintzman (CR27) 2009; 459 Dasiram, Ganesan, Kannan, Kotteeswaran, Sivalingam (CR41) 2017; 86 Balasubramanyam, Swaminathan, Ranganathan, Kundu (CR18) 2003; 278 Ehrenhofer-Murray (CR10) 2004; 271 Zhang (CR33) 2016; 48 Creyghton (CR8) 2010; 107 Aguirre (CR3) 2018; 8 Gao (CR13) 2013; 8 Ono, Basson, Ito (CR45) 2015; 13 Jones (CR4) 2008; 321 Morgan, Shilatifard (CR29) 2015; 29 Hessmann, Johnsen, Siveke, Ellenrieder (CR6) 2017; 66 Ogiwara (CR47) 2016; 6 Karmodiya, Krebs, Oulad-Abdelghani, Kimura, Tora (CR7) 2012; 13 Prigent, Dimitrov (CR20) 2003; 116 Diaferia (CR35) 2016; 35 Siegel, Miller, Jemal (CR1) 2019; 69 Schneider, Kramer, Schmid, Saur (CR9) 2011; 42 Gerrard, Boyd, Stein, Jin, Frietze (CR12) 2019 Kishimoto (CR21) 2015; 124 Balasubramanyam (CR19) 2004; 279 Tam, Weinberg (CR37) 2013; 19 Li, Zhang, Hill, Wang, Zhang (CR39) 2007; 67 Ono, Basson, Ito (CR23) 2016; 7 Bowers (CR17) 2010; 17 Watanabe (CR46) 2019; 145 Ernst (CR28) 2011; 473 Sengupta, George (CR30) 2017; 3 Roe (CR36) 2017; 170 Howe (CR11) 2001; 15 H Ono (89530_CR45) 2015; 13 XN Gao (89530_CR13) 2013; 8 T Oike (89530_CR15) 2014; 111 C Ghosh (89530_CR34) 2019; 10 AB Kunnumakkara (89530_CR40) 2007; 67 K Balasubramanyam (89530_CR18) 2003; 278 J Ernst (89530_CR28) 2011; 473 S Sengupta (89530_CR30) 2017; 3 RP Sahu (89530_CR43) 2009; 100 YH Lee (89530_CR14) 2012; 30 JS Roe (89530_CR36) 2017; 170 M Li (89530_CR39) 2007; 67 S Jones (89530_CR4) 2008; 321 GR Diaferia (89530_CR35) 2016; 35 JD Dasiram (89530_CR41) 2017; 86 H Ono (89530_CR23) 2016; 7 RL Siegel (89530_CR1) 2019; 69 C Prigent (89530_CR20) 2003; 116 G Schneider (89530_CR9) 2011; 42 D Hnisz (89530_CR31) 2013; 155 H Ogiwara (89530_CR47) 2016; 6 AE Ehrenhofer-Murray (89530_CR10) 2004; 271 DL Gerrard (89530_CR12) 2019 X Zhang (89530_CR33) 2016; 48 K Balasubramanyam (89530_CR19) 2004; 279 N Waddell (89530_CR5) 2015; 518 MP Creyghton (89530_CR8) 2010; 107 JE Bradner (89530_CR25) 2017; 168 WL Tam (89530_CR37) 2013; 19 H Ono (89530_CR44) 2014; 9 L Howe (89530_CR11) 2001; 15 TI Lee (89530_CR26) 2013; 152 L Rahib (89530_CR2) 2014; 74 S Hu (89530_CR42) 2018; 16 J Andricovich (89530_CR32) 2018; 33 D Pasini (89530_CR22) 2010; 38 E Hessmann (89530_CR6) 2017; 66 Q Jin (89530_CR24) 2011; 30 T Kishimoto (89530_CR21) 2015; 124 WA Flavahan (89530_CR38) 2017 AJ Aguirre (89530_CR3) 2018; 8 YM Wang (89530_CR16) 2017; 51 EM Bowers (89530_CR17) 2010; 17 ND Heintzman (89530_CR27) 2009; 459 K Karmodiya (89530_CR7) 2012; 13 MA Morgan (89530_CR29) 2015; 29 S Watanabe (89530_CR46) 2019; 145
References_xml	– volume: 7 start-page: 51301 year: 2016 end-page: 51310 ident: CR23 article-title: P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer publication-title: Oncotarget doi: 10.18632/oncotarget.10117 – volume: 74 start-page: 2913 year: 2014 end-page: 2921 ident: CR2 article-title: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-0155 – volume: 278 start-page: 19134 year: 2003 end-page: 19140 ident: CR18 article-title: Small molecule modulators of histone acetyltransferase p300 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M301580200 – volume: 38 start-page: 4958 year: 2010 end-page: 4969 ident: CR22 article-title: Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkq244 – volume: 86 start-page: 373 year: 2017 end-page: 380 ident: CR41 article-title: Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2016.12.034 – volume: 279 start-page: 51163 year: 2004 end-page: 51171 ident: CR19 article-title: Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription publication-title: J. Biol. Chem. doi: 10.1074/jbc.M409024200 – volume: 145 start-page: 192 year: 2019 end-page: 205 ident: CR46 article-title: Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality publication-title: Int. J. Cancer doi: 10.1002/ijc.32072 – volume: 30 start-page: 249 year: 2011 end-page: 262 ident: CR24 article-title: Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation publication-title: EMBO J. doi: 10.1038/emboj.2010.318 – volume: 107 start-page: 21931 year: 2010 end-page: 21936 ident: CR8 article-title: Histone H3K27ac separates active from poised enhancers and predicts developmental state publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1016071107 – volume: 15 start-page: 3144 year: 2001 end-page: 3154 ident: CR11 article-title: Histone H3 specific acetyltransferases are essential for cell cycle progression publication-title: Genes Dev. doi: 10.1101/gad.931401 – volume: 29 start-page: 238 year: 2015 end-page: 249 ident: CR29 article-title: Chromatin signatures of cancer publication-title: Genes Dev. doi: 10.1101/gad.255182.114 – volume: 9 start-page: e96060 year: 2014 ident: CR44 article-title: PTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling publication-title: PLoS ONE doi: 10.1371/journal.pone.0096060 – volume: 271 start-page: 2335 year: 2004 end-page: 2349 ident: CR10 article-title: Chromatin dynamics at DNA replication, transcription and repair publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.2004.04162.x – volume: 124 start-page: 417 year: 2015 end-page: 428 ident: CR21 article-title: Entry into mitosis: a solution to the decades-long enigma of MPF publication-title: Chromosoma doi: 10.1007/s00412-015-0508-y – volume: 10 start-page: 1554 year: 2019 end-page: 1571 ident: CR34 article-title: Super-enhancers: novel target for pancreatic ductal adenocarcinoma publication-title: Oncotarget doi: 10.18632/oncotarget.26704 – volume: 69 start-page: 7 year: 2019 end-page: 34 ident: CR1 article-title: Cancer statistics, 2019 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21551 – volume: 459 start-page: 108 year: 2009 end-page: 112 ident: CR27 article-title: Histone modifications at human enhancers reflect global cell-type-specific gene expression publication-title: Nature doi: 10.1038/nature07829 – volume: 6 start-page: 430 year: 2016 end-page: 445 ident: CR47 article-title: Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-15-0754 – volume: 30 start-page: 69 year: 2012 end-page: 74 ident: CR14 article-title: EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2012.966 – volume: 518 start-page: 495 year: 2015 end-page: 501 ident: CR5 article-title: Whole genomes redefine the mutational landscape of pancreatic cancer publication-title: Nature doi: 10.1038/nature14169 – volume: 48 start-page: 176 year: 2016 end-page: 182 ident: CR33 article-title: Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers publication-title: Nat. Genet. doi: 10.1038/ng.3470 – volume: 8 start-page: 1096 year: 2018 end-page: 1111 ident: CR3 article-title: Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0275 – year: 2019 ident: CR12 article-title: Disruption of broad epigenetic domains in PDAC cells by HAT inhibitors publication-title: Epigenomes doi: 10.3390/epigenomes3020011 – volume: 16 start-page: 1266 year: 2018 end-page: 1272 ident: CR42 article-title: Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells publication-title: Exp. Ther. Med. doi: 10.3892/etm.2018.6345 – volume: 155 start-page: 934 year: 2013 end-page: 947 ident: CR31 article-title: Super-enhancers in the control of cell identity and disease publication-title: Cell doi: 10.1016/j.cell.2013.09.053 – volume: 51 start-page: 1860 year: 2017 end-page: 1868 ident: CR16 article-title: Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines publication-title: Int. J. Oncol. doi: 10.3892/ijo.2017.4176 – volume: 33 start-page: 512 e518 year: 2018 end-page: 526 e518 ident: CR32 article-title: Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.02.003 – volume: 473 start-page: 43 year: 2011 end-page: 49 ident: CR28 article-title: Mapping and analysis of chromatin state dynamics in nine human cell types publication-title: Nature doi: 10.1038/nature09906 – volume: 66 start-page: 168 year: 2017 end-page: 179 ident: CR6 article-title: Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon? publication-title: Gut doi: 10.1136/gutjnl-2016-312539 – volume: 19 start-page: 1438 year: 2013 end-page: 1449 ident: CR37 article-title: The epigenetics of epithelial–mesenchymal plasticity in cancer publication-title: Nat. Med. doi: 10.1038/nm.3336 – volume: 100 start-page: 1425 year: 2009 end-page: 1433 ident: CR43 article-title: Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6605039 – volume: 67 start-page: 1988 year: 2007 end-page: 1996 ident: CR39 article-title: Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-3066 – volume: 13 start-page: 1174 year: 2015 end-page: 1184 ident: CR45 article-title: PTK6 Potentiates gemcitabine-induced apoptosis by prolonging S-phase and enhancing DNA damage in pancreatic cancer publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-15-0034 – volume: 35 start-page: 595 year: 2016 end-page: 617 ident: CR35 article-title: Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer publication-title: EMBO J. doi: 10.15252/embj.201592404 – volume: 170 start-page: 875 e820 year: 2017 end-page: 888 e820 ident: CR36 article-title: Enhancer reprogramming promotes pancreatic cancer metastasis publication-title: Cell doi: 10.1016/j.cell.2017.07.007 – volume: 168 start-page: 629 year: 2017 end-page: 643 ident: CR25 article-title: Transcriptional addiction in cancer publication-title: Cell doi: 10.1016/j.cell.2016.12.013 – volume: 17 start-page: 471 year: 2010 end-page: 482 ident: CR17 article-title: Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2010.03.006 – year: 2017 ident: CR38 article-title: Epigenetic plasticity and the hallmarks of cancer publication-title: Science doi: 10.1126/science.aal2380 – volume: 42 start-page: 85 year: 2011 end-page: 92 ident: CR9 article-title: Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma publication-title: J. Gastrointest. Cancer doi: 10.1007/s12029-011-9257-1 – volume: 321 start-page: 1801 year: 2008 end-page: 1806 ident: CR4 article-title: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses publication-title: Science doi: 10.1126/science.1164368 – volume: 111 start-page: 222 year: 2014 end-page: 227 ident: CR15 article-title: C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2014.03.015 – volume: 152 start-page: 1237 year: 2013 end-page: 1251 ident: CR26 article-title: Transcriptional regulation and its misregulation in disease publication-title: Cell doi: 10.1016/j.cell.2013.02.014 – volume: 3 start-page: 269 year: 2017 end-page: 281 ident: CR30 article-title: Super-enhancer-driven transcriptional dependencies in cancer publication-title: Trends Cancer doi: 10.1016/j.trecan.2017.03.006 – volume: 8 start-page: e55481 year: 2013 ident: CR13 article-title: A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells publication-title: PLoS ONE doi: 10.1371/journal.pone.0055481 – volume: 67 start-page: 3853 year: 2007 end-page: 3861 ident: CR40 article-title: Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-4257 – volume: 116 start-page: 3677 year: 2003 end-page: 3685 ident: CR20 article-title: Phosphorylation of serine 10 in histone H3, what for? publication-title: J. Cell Sci. doi: 10.1242/jcs.00735 – volume: 13 start-page: 424 year: 2012 ident: CR7 article-title: H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells publication-title: BMC Genomics doi: 10.1186/1471-2164-13-424 – volume: 30 start-page: 249 year: 2011 ident: 89530_CR24 publication-title: EMBO J. doi: 10.1038/emboj.2010.318 – volume: 145 start-page: 192 year: 2019 ident: 89530_CR46 publication-title: Int. J. Cancer doi: 10.1002/ijc.32072 – volume: 30 start-page: 69 year: 2012 ident: 89530_CR14 publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2012.966 – volume: 51 start-page: 1860 year: 2017 ident: 89530_CR16 publication-title: Int. J. Oncol. doi: 10.3892/ijo.2017.4176 – volume: 111 start-page: 222 year: 2014 ident: 89530_CR15 publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2014.03.015 – volume: 271 start-page: 2335 year: 2004 ident: 89530_CR10 publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.2004.04162.x – volume: 8 start-page: e55481 year: 2013 ident: 89530_CR13 publication-title: PLoS ONE doi: 10.1371/journal.pone.0055481 – volume: 33 start-page: 512 e518 year: 2018 ident: 89530_CR32 publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.02.003 – volume: 74 start-page: 2913 year: 2014 ident: 89530_CR2 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-0155 – volume: 42 start-page: 85 year: 2011 ident: 89530_CR9 publication-title: J. Gastrointest. Cancer doi: 10.1007/s12029-011-9257-1 – volume: 8 start-page: 1096 year: 2018 ident: 89530_CR3 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-18-0275 – volume: 9 start-page: e96060 year: 2014 ident: 89530_CR44 publication-title: PLoS ONE doi: 10.1371/journal.pone.0096060 – volume: 10 start-page: 1554 year: 2019 ident: 89530_CR34 publication-title: Oncotarget doi: 10.18632/oncotarget.26704 – volume: 67 start-page: 1988 year: 2007 ident: 89530_CR39 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-3066 – volume: 66 start-page: 168 year: 2017 ident: 89530_CR6 publication-title: Gut doi: 10.1136/gutjnl-2016-312539 – volume: 67 start-page: 3853 year: 2007 ident: 89530_CR40 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-4257 – volume: 17 start-page: 471 year: 2010 ident: 89530_CR17 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2010.03.006 – volume: 168 start-page: 629 year: 2017 ident: 89530_CR25 publication-title: Cell doi: 10.1016/j.cell.2016.12.013 – volume: 321 start-page: 1801 year: 2008 ident: 89530_CR4 publication-title: Science doi: 10.1126/science.1164368 – volume: 15 start-page: 3144 year: 2001 ident: 89530_CR11 publication-title: Genes Dev. doi: 10.1101/gad.931401 – volume: 459 start-page: 108 year: 2009 ident: 89530_CR27 publication-title: Nature doi: 10.1038/nature07829 – volume: 518 start-page: 495 year: 2015 ident: 89530_CR5 publication-title: Nature doi: 10.1038/nature14169 – volume: 279 start-page: 51163 year: 2004 ident: 89530_CR19 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M409024200 – volume: 48 start-page: 176 year: 2016 ident: 89530_CR33 publication-title: Nat. Genet. doi: 10.1038/ng.3470 – volume: 19 start-page: 1438 year: 2013 ident: 89530_CR37 publication-title: Nat. Med. doi: 10.1038/nm.3336 – year: 2017 ident: 89530_CR38 publication-title: Science doi: 10.1126/science.aal2380 – volume: 155 start-page: 934 year: 2013 ident: 89530_CR31 publication-title: Cell doi: 10.1016/j.cell.2013.09.053 – volume: 13 start-page: 1174 year: 2015 ident: 89530_CR45 publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-15-0034 – volume: 107 start-page: 21931 year: 2010 ident: 89530_CR8 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1016071107 – volume: 152 start-page: 1237 year: 2013 ident: 89530_CR26 publication-title: Cell doi: 10.1016/j.cell.2013.02.014 – volume: 86 start-page: 373 year: 2017 ident: 89530_CR41 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2016.12.034 – volume: 16 start-page: 1266 year: 2018 ident: 89530_CR42 publication-title: Exp. Ther. Med. doi: 10.3892/etm.2018.6345 – volume: 170 start-page: 875 e820 year: 2017 ident: 89530_CR36 publication-title: Cell doi: 10.1016/j.cell.2017.07.007 – volume: 7 start-page: 51301 year: 2016 ident: 89530_CR23 publication-title: Oncotarget doi: 10.18632/oncotarget.10117 – volume: 473 start-page: 43 year: 2011 ident: 89530_CR28 publication-title: Nature doi: 10.1038/nature09906 – volume: 35 start-page: 595 year: 2016 ident: 89530_CR35 publication-title: EMBO J. doi: 10.15252/embj.201592404 – volume: 29 start-page: 238 year: 2015 ident: 89530_CR29 publication-title: Genes Dev. doi: 10.1101/gad.255182.114 – volume: 69 start-page: 7 year: 2019 ident: 89530_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21551 – volume: 13 start-page: 424 year: 2012 ident: 89530_CR7 publication-title: BMC Genomics doi: 10.1186/1471-2164-13-424 – volume: 124 start-page: 417 year: 2015 ident: 89530_CR21 publication-title: Chromosoma doi: 10.1007/s00412-015-0508-y – volume: 3 start-page: 269 year: 2017 ident: 89530_CR30 publication-title: Trends Cancer doi: 10.1016/j.trecan.2017.03.006 – volume: 6 start-page: 430 year: 2016 ident: 89530_CR47 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-15-0754 – volume: 100 start-page: 1425 year: 2009 ident: 89530_CR43 publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6605039 – volume: 278 start-page: 19134 year: 2003 ident: 89530_CR18 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M301580200 – volume: 116 start-page: 3677 year: 2003 ident: 89530_CR20 publication-title: J. Cell Sci. doi: 10.1242/jcs.00735 – year: 2019 ident: 89530_CR12 publication-title: Epigenomes doi: 10.3390/epigenomes3020011 – volume: 38 start-page: 4958 year: 2010 ident: 89530_CR22 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkq244
SSID	ssj0000529419
Score	2.4589396
Snippet	The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl transferases).... Abstract The activity of histone acetyltransferases (HATs) plays a central role in an epigenetic modification in cooperation with HDACs (histone deacetyl...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	10078
SubjectTerms	631/67/1504/1713 692/4028/546 Acetylation Carcinogenesis Cell cycle Cell proliferation CREB-binding protein Cyclic AMP response element-binding protein Cyclin B1 Cyclin-dependent kinases Epigenetics Histone H3 Histones Humanities and Social Sciences Kinases Medical prognosis multidisciplinary Pancreatic cancer Patients Regulatory proteins Science Science (multidisciplinary) siRNA Transcription Tumors Xenografts
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDeBgozEDaKN3_axrSgVUjlRqTfLr6iRwFvtZg_994yd7NLleSGn-BHL8sx4ZjL2Nwi9JT46LQ0H36SvKcxM61hPWhV67RVU6gpffP5Znl3wT5fi8laqr3ImbIIHnhZukYJmoDRD3xnHvYvgLyjXJ6KUdrQLFeezM90tZ2pC9aaGEzPfkumYXqxBU5XbZJS02gjWtXpPE1XA_t9Zmb8elvwpYloV0ekDdH-2IPHRNPOH6E7Kj9DdKafkzWPUn0gu8ZCvBj-Ma_yRLs5x-TuPww10b-vdlRRxxWcY8hq7DAV4zyDqYHZCeRzacfNtucLzWQ8YDMOeMZmXAYfCJ6sn6OL0w5eTs3ZOptAG8FHGFtyqlHhiLkQRuBA9DTI5xaL0KlHTg6ETfImZ8ihBqg2P0UkKW2XnvIFq9hQd5GVOzxEWlIMkq8hD50AHKq880SoGYagKKcQGke3C2jAjjZeEF19tjXgzbSdiWCCGrcSwukHvdt9cTzgbf-19XOi161kwsmsFcI6dOcf-i3MadLiltp0Fd22poELDQ0yD3uyaQeQKpVxOy03tI0u4l_AGPZuYYzcTxowGE4w0SO2xzd5U91vycFVhvXUxzjmM-X7LYD-m9eelePE_luIlukeLZBRUWnqIDsbVJr0CY2v0r6tcfQcfQCPV priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxg2jjR2L7hKCiVEjlRKW9WX6FRipJ2WQP_feMHW-q5dFb_EjkeGY833jsGYTeEuuNbBQH26RNKcxUaVhLSuFaaQVUyhS--PRbc3LGv67rdd5wG_Oxyt2amBZqP7i4R76iNa3BWgMF9uHyVxmzRkXvak6hcRvdIYBEYuoGsRbLHkv0YnGi8l2ZisnVCPoq3imjpJSqZlUp9_RRCtv_L6z595HJP_ymSR0dP0D3M47EH2fCP0S3Qv8I3Z0zS149Ru1Rwxvc9eed7aYRf6GrUxz36LG7gu5lusESPE5RGrp-xKaHAjz3IPAAPqE8deW0_TlscD7xAR_DsHLMINNhF7ll8wSdHX_-fnRS5pQKpQNLZSrBuAqBB2acrx2v65a6JhjBfGNFoKoFuONs9Jxy34BsK-69aSgsmJWxCqrZU3TQD314jnBNOciz8NxVBjShsMISKbyrFRUuOF8gsptY7XK88Zj24kInvzeTeiaGBmLoRAwtC_RueedyjrZxY-9PkV5LzxgpO1UMmx86C54OTjIAXa6tlOHWeLA3hWkDEUIaWjlWoMMdtXUW31FfM1uB3izNIHiRUqYPwzb1aaLTl_ACPZuZYxkJY0oCECMFEntsszfU_Za-O0_BvWWE6By--X7HYNfD-v9UvLj5L16iezTyfIw6Sw_RwbTZhlcApib7OknMb-a3GvE priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrZC4IN4ECjISN4gaPxLbx6WiVCuVC1TqLfIrNFLJot3sof-esfNACwWJnBJ7ElmeGfubjP0Z4C213qhKC4xNmnSEmc4Nb2guXaOsxEKV6IvPP1dnF2J1WV4eAJv2wqRF-4nSMg3T0-qw4y1ONHEzGKO50iUvcnUHDpXE4XcBh8vl6stq_rMSc1eC6nGHTMHVLS_vzUKJrP82hPnnQsnfsqVpEjp9APdH9EiWQ3sfwkHoHsHd4TzJm8fQnFSiIm131dq235JP7PicxD_zxN2geJ72rQRPEjdD222J6fAB7zt0c4Sc-Ny3eb_7vt6QcZ0HfozgeDFAS0dctJHNE7g4_fj15CwfD1LIHcYnfY4hVQgicON86URZNsxVwUjuKysD0w2CHGdjvlT4Cj1aC-9NxXCYLIzVWMyfwqJbd-E5kJIJ9GLphSsMzn_SSkuV9K7UTLrgfAZ06tjajSzj8bCL6zplu7mqB2XUqIw6KaNWGbyb3_kxcGz8U_pD1NcsGfmxU8F6860e7aUOTnGEWq4ptBHWeIwypWkClVIZVjiewdGk7Xp02m3NSlYqvKjO4M1cje4WNWW6sN4lmSqmeqnI4NlgHHNLONcK4RfNQO6ZzV5T92u69ipReqsIzAV-8_1kYL-a9feuePF_4i_hHos-ELln2REs-s0uvEJI1dvXow_9BMizGhg priority: 102 providerName: Springer Nature
Title	C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer
URI	https://link.springer.com/article/10.1038/s41598-021-89530-8 https://www.ncbi.nlm.nih.gov/pubmed/33980911 https://www.proquest.com/docview/2525888819 https://www.proquest.com/docview/2526302714 https://pubmed.ncbi.nlm.nih.gov/PMC8115044 https://doaj.org/article/ec83439cf09a4bad9247afe1778a20c3
Volume	11
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_tQ0i8IL4JjMpIvEFY4jix_YBQV21MlTYhoFLfIsd2WKSRbmkq0f-es5MUFQoSeWniuJblu7N_l7N_B_A6LowSmWTom5Q-hZkMVVLGIdelKDgWCk9ffHGZnc_YdJ7O92BId9QP4HKna-fySc2a63c_btcf0ODfd0fGxfESFyF3UIzGoZBpEoViHw59vMht5evhfsf1TSXzuT4cCXuIYIL252h2N7O1VnlK_1049M_tlL_FVP1SdXYf7vUYk4w7pXgAe7Z-CHe6rJPrR1BOMpaRqr6qiqpdko_0-IK47_dEr7F66E-3WEM8g0NVL4mq8QHva5wMEJjic1uF7er7oiH9bhBsjOCs0gFQTbTTpOYxzM5Ov07Owz7dQqjRi2lDdLysZTZR2qSapWlJdWYVT0xWcEtliVBIFy6qykyGdi-ZMSqjOJlGqpBYnDyBg3pR22dAUsrQ1rlhOlIoB17wIhbc6FRSrq02AcTDwOa65yJ3KTGucx8TT0TeCSNHYeReGLkI4M3mPzcdE8c_a584eW1qOhZtX7BovuW9UeZWiwQBmS4jqVihDPqiXJU25lwoGukkgKNB2vmgmTlNaSrwimUArzav0SidpFRtFytfJ3MB4ZgF8LRTjk1PkkQKBGlxAHxLbba6uv2mrq488bdw8J1hm28HBfvVrb8PxfP_GrgXcJc6E3AEtfQIDtpmZV8i7mqLEezzOR_B4Xg8_TLF35PTy0-fsXSSTUb-W8bIm9tP04oplw
linkProvider	Scholars Portal
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgheEN8EBhgJniBq4jix8zAhNjY6tlYIbdLejGM7LBKko02F-s_xt3F2kk7lY297axzXcnznu9_5fHcAL-PCKJHlDG2T0pcwy0OVlHHIdSkKjo3Cpy8eT7LRCft4mp5uwK8-FsZdq-xlohfUZqrdGfmQpjRFaw0V2NvzH6GrGuW8q30JDdWVVjDbPsVYF9hxaJc_0YSbbx-8R3q_onR_73h3FHZVBkKN4L0J0d6wltlEaZNqlqYl1ZlVPDFZwS3NS0QAunDORGYyZPecGaMyijIkUkWOzQmOew02mTtAGcDmzt7k0-fVKY_zo7E476J1okQM56gxXVQbjUORp0kUijWN6AsH_Avt_n1p8w_PrVeI-7fhVodkybuW9e7Ahq3vwvW2tuXyHpS7GctIVZ9VRdXMyQc6HBPnJSB6id1DH0NjDfF5Iqp6TlSND_gbl9fBX3xuqrBZfJ_OSHfnBAcjKLtamKuJdvw6uw8nV7LcD2BQT2v7CEhKGUoUbpiOFOpiXvAiFtzoNKdcW20CiPuFlbrLeO4Kb3yT3vOeCNkSQyIxpCeGFAG8Xv3nvM33cWnvHUevVU-Xq9s3TGdfZbf1pdUiQdinyyhXrFAGLV6uShtzLhSNdBLAVk9t2QmQubxg9wBerF7j1neUUrWdLnyfzLmdYxbAw5Y5VjNJklwgFIwD4GtsszbV9Td1debTiwtnJDAc803PYBfT-v9SPL78K57DjdHx-EgeHUwOn8BN6vjf5cClWzBoZgv7FKFdUzzr9g-BL1e9ZX8D3sxeDw
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlAviDeBAkaCE0Sb2E7sHBCClqWltOJApb0Zx3ZopJItu1mh_Wv8OsZOstXy6K23xHEsx_PNK2PPADxPS6tlXnD0TapQwqyINavSWJhKlgIbZUhffHiU7x3zj5NssgG_hrMwflvlIBODoLZT4_-Rj2hGM_TWUIGNqn5bxOfd8ZuzH7GvIOUjrUM5jQ4iB275E923-ev9XaT1C0rH77_s7MV9hYHYoOHexuhrOMcd08ZmhmdZRU3utGA2L4WjRYXa35Q-kMhtjlAvuLU6pyg_El0W2Mxw3CtwVTDOfdkIMRGr_zs-gsbToj-nkzA5mqOu9OfZaBrLImNJLNd0YSgZ8C879-_tmn_EbIMqHN-EG70NS952oLsFG665Dde6qpbLO1Dt5DwndXNSl3U7Jx_o6JD4-AAxS-weh9MzzpKQIaJu5kQ3eIPXDQobNHzxvq3jdvF9OiP9bhMcjKDU6gxcQ4xH6uwuHF_KYt-DzWbauAdAMspRlgjLTaJRC4tSlKkU1mQFFcYZG0E6LKwyfa5zX3LjVIWYO5OqI4ZCYqhADCUjeLl656zL9HFh73eeXquePkt3aJjOvqme6ZUzkqHBZ6qk0LzUFn1doSuXCiE1TQyLYHugtupFx1ydAz2CZ6vHyPSeUrpx00Xok_uAc8ojuN-BYzUTxgqJRmAagViDzdpU15809UlILC69e8BxzFcDwM6n9f-leHjxVzyF68io6tP-0cEj2KIe_j75Ld2GzXa2cI_RpmvLJ4F5CHy9bG79DUYbW6s
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=C646+inhibits+G2%2FM+cell+cycle-related+proteins+and+potentiates+anti-tumor+effects+in+pancreatic+cancer&rft.jtitle=Scientific+reports&rft.au=Ono%2C+Hiroaki&rft.au=Kato%2C+Tomotaka&rft.au=Murase%2C+Yoshiki&rft.au=Nakamura%2C+Yutaro&rft.date=2021-05-12&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-89530-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41598_021_89530_8
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon